These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33470885)

  • 21. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Key miRNAs in the Treatment of Dabrafenib-Resistant Melanoma.
    Gao G; Yao Z; Shen J; Liu Y
    Biomed Res Int; 2021; 2021():5524486. PubMed ID: 33880366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
    Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
    PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioinformatics analysis of key biomarkers and potential molecular mechanisms in hepatocellular carcinoma induced by hepatitis B virus.
    Li Z; Xu J; Cui H; Song J; Chen J; Wei J
    Medicine (Baltimore); 2020 May; 99(20):e20302. PubMed ID: 32443377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of aberrantly methylated differentially expressed genes and validation of CDC6 in melanoma.
    Liao L; Han W; Shen Y; Shen G
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):362. PubMed ID: 39052109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of key candidate genes involved in melanoma metastasis.
    Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
    Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma.
    Zhao CC; Guo H; Wang Y; Li JH
    Hum Cell; 2021 Mar; 34(2):654-666. PubMed ID: 33400243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and potential molecular mechanisms of miR‑204‑5p in breast cancer, based on bioinformatics and a meta‑analysis of 2,306 cases.
    Cai KT; Liu AG; Wang ZF; Jiang HW; Zeng JJ; He RQ; Ma J; Chen G; Zhong JC
    Mol Med Rep; 2019 Feb; 19(2):1168-1184. PubMed ID: 30569120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
    Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
    J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
    Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
    Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis.
    He S; Shi J; Mao J; Luo X; Liu W; Liu R; Yang F
    Pathol Res Pract; 2019 Jun; 215(6):152375. PubMed ID: 30879885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
    Hu D; Zhang B; Yu M; Shi W; Zhang L
    Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.